What “bionic eye” actually means
“Bionic eye” is a popular label, not a precise technical term. It is usually applied to a visual prosthesis: a system that uses a camera or a light-sensitive chip, some electronics and a set of tiny electrodes to stimulate part of the visual system. The goal is for a blind person to perceive patterns of light that can be useful in daily life.
It does not replace the eye the way a prosthetic limb replaces an arm, and it does not restore normal sight. Most of these systems were designed for people who lost vision because the light-sensing cells of the retina degenerated, as in retinitis pigmentosa, while the rest of the visual pathway still worked. People whose blindness comes from other causes, such as damage to the optic nerve, are generally outside what the best-known systems were built for.
The basic idea: making the brain see light
The idea rests on an old observation. Electrical stimulation of the eye or the visual part of the brain can make a person see small spots or flashes of light, called phosphenes. Accounts from the eighteenth century describe flashes of light seen after electrical shocks, and in the twentieth century researchers stimulated the brain’s surface in patients during surgery and recorded similar spots of light.
A bionic eye tries to turn that effect into a pattern. A camera captures a scene, a processor reduces it to a coarse grid of bright and dark points, and electrodes deliver small pulses so that the person perceives a rough version of the pattern. The picture is far simpler than what the camera records, because the number of electrodes is small and each one produces a blurry spot rather than a clean pixel.
Three places to put the electrodes
Researchers have worked at three broad locations along the visual pathway.
- The retina. Devices can sit on the inner surface of the retina (epiretinal), beneath it (subretinal), or between other layers at the back of the eye (suprachoroidal). This is the most developed approach, and it depends on the retina’s remaining cells still being able to pass signals on.
- The optic nerve. A small number of experiments placed electrodes around the nerve that carries signals from the eye to the brain. This approach has seen less development.
- The visual cortex. Electrodes on or in the brain’s visual area bypass the eye entirely. This is the oldest route in the research record, and it could in principle help people whose eyes or optic nerves are damaged, but it involves brain surgery and carries greater risks.
Each location has trade-offs in surgery, stability and how the stimulation is perceived.
A short timeline
Experiments with brain stimulation in the early twentieth century established that spots of light could be produced on demand. In 1968, Giles Brindley and Walpole Lewin in London reported implanting a set of electrodes over the visual cortex of a blind volunteer, who saw phosphenes when individual electrodes were activated. Later decades brought portable cortical systems and a growing effort on the retina, where surgeons already had experience.
Retinal prototypes were implanted in volunteers in the early 2000s. Around 2011 to 2013, the first retinal systems received regulatory approval for sale in Europe and, in one case, the United States. These approvals covered narrow groups of patients with advanced inherited retinal disease. Exact dates and approval details vary by device and region, so they are best checked against the manufacturers’ and regulators’ own records.
What these systems can and cannot do
Users of the best-known retinal systems have generally described perceiving light, movement and the outlines of large objects, and in trials some could locate a doorway or a high-contrast shape. Some could, with effort, pick out large letters under favorable conditions. Results varied widely from person to person, and learning to interpret the signals took training.
The limits are just as important.
- The picture is very coarse, usually far short of recognizing faces or reading ordinary print.
- Benefits depend on the person, the type of disease and the amount of rehabilitation.
- Surgery carries risks, including infection, inflammation and device problems.
- Some people were left without technical support when a manufacturer stopped operating, which raised questions about how long such devices can be maintained. Reports on this point appeared around 2020 to 2022.
Whether a particular system suits a particular person is a medical question for specialists, not something history can answer.
Related technology
Bionic eyes belong to a wider family of neuroprosthetics, devices that connect electronics to the nervous system. The cochlear implant is the best-known success in this family. Vision has proved harder than hearing, partly because the eye sends far more information to the brain than the ear does, and the optic nerve contains about a million fibers while a device offers dozens or a few thousand points of stimulation.
Work on brain-computer interfaces and implanted electrodes in the cortex has revived interest in direct brain stimulation for vision. Modern image processing, including artificial intelligence, may help by emphasizing the most useful parts of a scene before it is sent to the electrodes, although this remains experimental.
Other lines of research take a different path altogether. Gene therapy aims to treat specific inherited conditions, and optogenetics tries to make surviving retinal cells sensitive to light. These are also at various stages of study, and none is described here as a proven way of restoring sight.
How to read claims about the bionic eye
Headlines about a “bionic eye” often compress a long, uncertain process. A device that produces flashes in a handful of volunteers is a real scientific milestone, but it is a long way from a general cure for blindness. When reading about a new system, it helps to ask how many electrodes it has, how many people have received it, what they could actually do with it, and how long it has worked. Answers to those questions tell far more than the label does.